• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·SRPT
Held by 3 Gurus
Share

Sarepta Therapeutics, Inc. Stocks

$ 20.45Last Updated 11.09.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

$ 2.16B

In Guru Portfolios

Bob Prince, Greg Jensen, Karen Karniol-Tambour

Portfolio Weight (%)

0.0%

Change

-0.00%

Fund

Bridgewater Associates

Steven Cohen

Portfolio Weight (%)

0.0%

Change

+0.01%

Fund

Point72 Asset Management, L.P.

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

-0.01%

Fund

CITADEL ADVISORS LLC

Manager
Fund
Portfolio Weight (%)
Change
Bob Prince, Greg Jensen, Karen Karniol-TambourBridgewater Associates0.0%-0.00%
Steven CohenPoint72 Asset Management, L.P.0.0%+0.01%
Kenneth GriffinCITADEL ADVISORS LLC0.0%-0.01%

Trending

15.09.2026 09:30

Roblox announced new game development tools. Its stock rose 13%.

15.09.2026 08:30

UBS sees GM as an “opportunity undervalued by the market.” The stock could rise by a third

15.09.2026 07:00

Leading AI developers have decided to slow down its development. What should investors do?

15.09.2026 03:19

Revolut Leaked the Data of Nearly 700 Customers to Scammers — FT

15.09.2026 02:34

Bitcoin and crypto stocks rose ahead of an important Senate vote. What will it change?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026